SonoScape Medical Corp. (SHE:300633)
China · Delayed Price · Currency is CNY 19.26
-0.69 (-3.46%)
Sep 11, 2026, 3:04 PM CST
SonoScape Medical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 907.1 | 1,427 | 1,571 | 1,775 | 1,337 | 1,269 |
Trading Asset Securities | 179.59 | 237.16 | 438.46 | 51.39 | 419.45 | 145.24 |
Cash & Short-Term Investments | 1,087 | 1,664 | 2,009 | 1,826 | 1,757 | 1,415 |
Cash Growth | -28.16% | -17.18% | 10.05% | 3.95% | 24.17% | 57.27% |
Accounts Receivable | 270.4 | 302.41 | 219.51 | 174.22 | 200.05 | 210.1 |
Other Receivables | 10.64 | 11.99 | 23.82 | 18.73 | 22.67 | 43.94 |
Receivables | 281.04 | 314.4 | 243.32 | 192.95 | 222.72 | 254.05 |
Inventory | 963.14 | 763.6 | 653.08 | 531.48 | 514.38 | 440.52 |
Other Current Assets | 96.11 | 73.72 | 69.13 | 74.96 | 20.55 | 22.98 |
Total Current Assets | 2,427 | 2,816 | 2,975 | 2,625 | 2,514 | 2,132 |
Property, Plant & Equipment | 1,123 | 1,120 | 936.34 | 719.89 | 594.55 | 482.68 |
Long-Term Investments | 0.79 | 0.79 | 1.22 | 8.2 | 8.2 | 8.2 |
Goodwill | 103.51 | 108.7 | 112.51 | 165.9 | 160.44 | 146.41 |
Other Intangible Assets | 141.24 | 145.07 | 155.65 | 164.85 | 169.37 | 179.06 |
Long-Term Deferred Tax Assets | 108.09 | 93.01 | 52.35 | 30.6 | 30.38 | 32.33 |
Long-Term Deferred Charges | 26.06 | 29.17 | 35.13 | 17.93 | 13.75 | 4.75 |
Other Long-Term Assets | 151.29 | 87.49 | 35.68 | 24.18 | 36.53 | 15.12 |
Total Assets | 4,088 | 4,406 | 4,313 | 3,771 | 3,544 | 3,020 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 380.87 | 367.11 | 331.55 | 186.15 | 231.43 | 231.52 |
Accrued Expenses | 176.11 | 284.72 | 259.09 | 245.28 | 181.94 | 174.72 |
Short-Term Debt | 46.95 | 230.73 | 262.21 | 23.63 | 180.97 | 28.55 |
Current Portion of Long-Term Debt | 39.96 | 0.02 | 0.02 | - | - | - |
Current Portion of Leases | 13.68 | 14.27 | 16.57 | 14.81 | 10.83 | 12.88 |
Current Income Taxes Payable | 6.76 | 1.98 | 0.58 | 2.08 | 4.68 | 5.58 |
Current Unearned Revenue | 90.89 | 70.27 | 151.44 | 44.59 | 100.36 | 53.13 |
Other Current Liabilities | 58.28 | 51.07 | 61.83 | 52.08 | 39.21 | 49.46 |
Total Current Liabilities | 813.5 | 1,020 | 1,083 | 568.62 | 749.42 | 555.83 |
Long-Term Debt | 180.02 | 39.97 | 40 | - | - | 43.32 |
Long-Term Leases | 20.33 | 25.16 | 35.99 | 34.01 | 27.09 | 26 |
Long-Term Unearned Revenue | 57.45 | 58.52 | 45.5 | 22.83 | 26.91 | 33.37 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 1.01 | 6.66 |
Total Liabilities | 1,071 | 1,144 | 1,205 | 625.46 | 804.43 | 665.18 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 424.84 | 432.71 | 432.71 | 430.65 | 427.86 | 429.77 |
Additional Paid-In Capital | 970.61 | 1,146 | 1,142 | 1,119 | 1,038 | 1,011 |
Retained Earnings | 1,729 | 1,791 | 1,637 | 1,633 | 1,256 | 939.23 |
Treasury Stock | -120.03 | -120.03 | -120.03 | -59.99 | - | -27.98 |
Comprehensive Income & Other | 11.89 | 12.87 | 16 | 23.78 | 18.57 | 2.72 |
Shareholders' Equity | 3,016 | 3,262 | 3,108 | 3,146 | 2,740 | 2,355 |
Total Liabilities & Equity | 4,088 | 4,406 | 4,313 | 3,771 | 3,544 | 3,020 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 300.95 | 310.14 | 354.79 | 72.44 | 218.89 | 110.74 |
Net Cash (Debt) | 785.74 | 1,354 | 1,655 | 1,754 | 1,538 | 1,304 |
Net Cash Growth | -36.87% | -18.16% | -5.64% | 14.03% | 17.93% | 188.04% |
Net Cash Per Share | 1.83 | 3.16 | 3.83 | 4.05 | 3.58 | 3.27 |
Filing Date Shares Outstanding | 422.45 | 430.32 | 429.82 | 429.41 | 427.86 | 429.77 |
Total Common Shares Outstanding | 422.45 | 430.32 | 429.82 | 429.41 | 427.86 | 429.77 |
Working Capital | 1,613 | 1,796 | 1,892 | 2,057 | 1,765 | 1,576 |
Book Value Per Share | 7.14 | 7.58 | 7.23 | 7.33 | 6.40 | 5.48 |
Tangible Book Value | 2,772 | 3,009 | 2,840 | 2,815 | 2,410 | 2,030 |
Tangible Book Value Per Share | 6.56 | 6.99 | 6.61 | 6.56 | 5.63 | 4.72 |
Buildings | 308.25 | 303.73 | 298.49 | 296.83 | 284.92 | 13.81 |
Machinery | 534.59 | 518.75 | 361.58 | 249.19 | 183.14 | 162.61 |
Construction In Progress | 523.2 | 493.43 | 393.94 | 254.2 | 181.3 | 373.39 |